Linkage with methadone treatment upon release from incarceration: A promising opportunity

Journal of Addictive Diseases

Volumn 24, Issue 3, 2005, Pages 49-59

  Rich, Josiah D ^a,b,e   McKenzie, Michelle ^a,b   Shield, David C ^a,b   Wolf, Francis A ^a,b   Key, R Garrett ^c   Poshkus, Michael ^a,b   Clarke, Jennifer ^d  

^a BROWN UNIVERSITY   (United States)

^b Miriam Immunology Center   (United States)

^c TEXAS TECH UNIVERSITY   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e MIRIAM HOSPITAL   (United States)

Author keywords

Hepatitis B; Hepatitis C; HIV; Incarceration; Methadone; Opiate dependence; Tuberculosis

Indexed keywords

METHADONE; OPIATE;

ARTICLE; DISEASE TRANSMISSION; DRUG EFFICACY; HEALTH CARE FACILITY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; METHADONE TREATMENT; OFFENDER; OPIATE ADDICTION; PRISON; TUBERCULOSIS; UNITED STATES; VIRUS HEPATITIS;

CRIME; HEALTH SERVICES NEEDS AND DEMAND; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; LONG-TERM CARE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; PRISONERS; RECURRENCE; REFERRAL AND CONSULTATION; RISK; SUBSTANCE ABUSE, INTRAVENOUS; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 27544444082     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v24n03_04     Document Type: Article

References (50)

1. Beck AJ, Harrison PM, Karberg JC. Prison and Jail Inmates at Midyear 2001. Bureau of Justice Statistics Bulletin. US Department of Justice, Office of Justice Programs. 2003; NCJ 198877.
2. Federal Bureau of Investigation. Uniform Crime Reports: Crime in the United States. [internet] Washington, DC [cited June 17, 2005]. Available from: http://www.fbi.gov/ucr/ucr.htm
3. Centers for Disease Control and Prevention. Drug use, HIV, and the criminal justice system. (PDF 528 KB, 4 pages) IDU/HIV Prevention. Atlanta (GA): Centers for Disease Control and Prevention; Aug 2001 [cited June 17, 2005]. Available from: www.cdc.gov/idu/facts/druguse.htm
4. Belenko S. Behind Bars: Substance Abuse and America's Prison Population. (PDF 1110 KB, 282 pages) New York: National Center on Addiction and Substance Abuse at Columbia University (CASA); 1998 [cited July 17, 2005]. Available from: http://www.casacolumbia.org/Absolutenm/articlefiles/5745.pdf
5. Gaughwin M, Douglas R, Liew C, et al. HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS. 1991; 5: 845-51.
6. U.S Department of Justice, Bureau of Justice Statistics. HIV in Prisons and Jails, 1999. (PDF 96 KB, 12 pages) Washington, DC: USDOJ/BJS; July 2001. [cited June 17, 2005] NCJ 187456. Available from: http://www.ojp.usdoj.gov/bjs/ abstract/hivpj99.htm
7. Dean-Gaitor H, Fleming PL. Epidemiology of AIDS in incarcerated persons in the United States. 1994-1996. AIDS. 1999; 13: 2429-35.
8. Rich JD, Chin-Hong PV, Busi KA, Mayer KH, Flanigan TP. Hepatitis C and HIV in male prisoners [letter]. Journal of Acquired Immune Deficiency Syndromes. 1997; 16: 408-9.
9. Spaulding A, Greene C, Davidson K, Schneidermann M, Rich JD. Hepatitis C in state correctional facilities. Preventive Medicine. 1999; 28: 92-100.
10. Reindollar RW. Hepatitis C and the correctional population. American Journal of Medicine. 1999; 107(6B): 100S-103S.
11. Sperling C, Burton R. The Use of Focus Groups in Examining Prevention Strategies for Men with Previous Jail Incarcerations. [abstract] San Diego (CA): National STD Prevention Conference; March 2002.
12. Nurco DN, Hanlon TE, Kinlock TW. Recent research on the relationship between illicit drug use and crime. Behavioral Sciences and the Law. 1991; 9: 221-242.
13. Hanlon TE, Nurco DN, Kinlock TW, Duszynski KR. Trends in criminal activity and drug use over an addiction career. American Journal of Drug and Alcohol Abuse. 1990; 16(3-4): 223-38.
14. Nurco DN, Stephenson PE, Hanlon TE. Aftercare/relapse prevention and the self-help movement. Addiction. 1990-1991; 25(9A-10A): 1179-1200.
15. Inciardi JA, McBride D, Suratt H. The Heroin Street Addict: Profiling a National Population. In: Inciardi JA, Harrison LD, eds, Heroin in the age of crack-cocaine. Thousand Oaks, CA: Sage. 1998: 31-50.
16. Weatherburn D, Lind B. Heroin harm minimisation: Do we really have to choose between law enforcement and treatment? New South Wales Crime and Justice Bulletin. 1999; 46: 1-11.
17. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. [internet] Washington, DC; 2000 [cited June 17, 2005]. Available from: http://www.samhsa.gov
18. Lipton DS, Falkin GP, Wexler HK. Correctional Drug Abuse Treatment in the United States: An Overview. In: Leukefeld CG, Tims FM, eds., Drug Abuse Treatment in Prisons and Jails. New York (NY): Narcotic and Drug Research Inc.; 1992. pp. 8-30. (National Institute on Drug Abuse Research Monograph Series; 118).
19. Gore SM, Bird AG, Burns SM, Goldberg DJ, Ross AJ, Macgregor J. Drug injection and HIV prevalence in inmates of Glenochil prison. British Medical Journal. 1995; 310: 293-296.
20. Dolan K, Hall W, Wodak A. The Provision of Methadone Within Prison Settings. In: Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Ward J, Mattick RP, Hall W, eds. Australia: Harwood Academic Publishers: 1998. pp. 379-396
21. Kinloek TW, Batties RJ, Schwartz RP. A novel opioid maintenance program for prisoners: preliminary findings. Journal of Substance Abuse Treatment. 2002; 22(3): 141-147.
22. Metzger D, Navaline H, Woody G. Drug abuse treatment as AIDS prevention. Public Health Reports. 1998; 133: 97-106.
23. Booth RE, Kwiatkowski C, Iguchi MY, Pinto F, John D. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Reports. 1998; 113: 116-128.
24. United States General Accounting Office. Needle Exchange Programs: Research Suggests a Promising AIDS Strategy. Report: GAO/HRD-93-60. (PDF 2684 KB, 38 pages) Washington, DC: US Government Printing Office; 1993. Available from: http://archive.gao.gov/d44t15/148846.pdf
25. Ward J, Mattick RP, Hall W, eds. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Australia: Harwood Academic Publishers; 1998, 471p.
26. Dole V, Robinson JW, Orraca J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. New England Journal of Medicine 1969; 280(25): 1372-1375.
27. Newman RG, Whitehill WB. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet. 1979; 2(8141): 485-488.
28. Gunne LM, Gronhladh L. The Swedish methadone maintenance program: A controlled study. Drug and Alcohol Dependency. 1981; 7(3): 249-256.
29. Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ. The impact of harm-reduction-based methadone treatment on mortality among heroin users. American Journal of Public Health. 2001; 91(5): 774-780.
30. Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York: Springer; 1991.
31. McLellan AT, Arndt IO, Metzger DS, et al. The effects of psychosocial services in substance abuse treatment. JAMA. 1993; 269: 1953-1959.
32. Capelhom JRM, Ross MW. Methadone maintenance and the likelihood of risky needle-sharing. Addiction. 1995; 30: 685-698.
33. Longshore D, Hsieh S, Danila B, et al. Methadone maintenance and needle-syringe sharing. Addiction. 1993; 28: 983-996.
34. Metzger DS, Woody GE, McLellan AT. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. AIDS. 1993; 6: 1049-56.
35. Ball JC. Ross A. The Effectiveness of Methadone Maintenance Treatment. New York: Springer-Verlag; 1991: 166-70.
36. Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior. 1988; 29: 214-26.
37. Ward J, Mattick R, Hall W. Key Issues in Methadone Maintenance Treatment. New South Wales. Australia: New South Wales University Press; 1992: 46-61.
38. Martin SS, Butzin CA, Saum CA, Inciardi, JA. Three year outcomes of therapeutic community treatment for drug involved offenders in Delaware: From prison to work release to aftercare. The Prison Journal. 1999; 79(3): 294-320.
39. National Institute on Drug Abuse (NIDA). Principles of Drug Addiction Treatment: A Research Based Guide. (PDF 236 KB, 56 pages) Washington, DC; October 1999 [cited June 17, 2005]. Available from: http://www.nicla.nih.gov/ PODAT/PODAT1. html
40. Fallon BM. The key extended entry program (KEEP): From the community side of the bridge. Mount Sinai Journal of Medicine. 2001; 68: 21-27.
41. Tomasino V, Swanson AJ, Nolan J, Shuman HI. The key extended entry program (KEEP): A methadone treatment program for opiate-dependent inmates. Mount Sinai Journal of Medicine. 2001; 68: 14-20.
42. Magura S, Rosenblum A, Joseph H. Evaluation of in-jail methadone maintenance: Preliminary results. Washington, DC: 1992; 118: 192-210. (NIDA Research Monograph; 188).
43. Belenko S. Behind Bars: Substance Abuse and America's Prison Population. (PDF KB, 282 pages) New York: National Center on Addiction and Substance Abuse at Columbia University (CASA); 1998. Available from: http://www.casacolumbia. org/Absolutenm/articlefiles/5745.pdf
44. Herman J, Stancliff S, Langrod, J. Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mount Sinai Journal of Medicine. 2000; 67: 347-364.
45. Yoast R, Williams MA, Deitchman SD, Champion HC. Report of the Council on Scientific Affairs: Methadone maintenance and needle-exchange programs to reduce the medical and public health consequences of drug abuse. Journal of Addiction Disease. 2001; 20: 15-40.
46. National Institutes of Health. Effective medical treatment of opiate addiction. NIH Consensus Statement. 1997; 15: 1-38.
47. Sibbald B. Methadone maintenance expands inside federal prisons. CMAJ. 2002; 167(10): 1154.
48. US Department of Justice, Bureau of Justice Statistics. State Prison Expenditures, 1999. (PDF 159 KB, 23 pages) Washington, DC: USDOJ/BJS: August 1999 [cited July 17, 2005]. NCJ 172211. Available from: http://www.ojp.usdoj. gov/bjs/pub/pdf7/spe96.pdf
49. Kreek, MJ, Vocci, FJ. History and current status of opioid maintenance treatments: Blending conference session. Journal of Substance Abuse Treatment. 2002; 23(2): 93-105.
50. Smith-Rohrberg D, Bruce RD, Altice FL. Research note-Review of corrections-based therapy for opiate dependent patients: Implications for buprenorphine treatment among correctional populations. Journal of Drug Issues. 2004; 34(2): 451-480.